In a recent interview with MedCity, Dr Ulrike Lorch, Medical Director at Richmond Pharmacology, discussed her new position as Director of Human Pharmacology at the Faculty of Pharmaceutical Medicine and the importance of flexible training programmes in ensuring that London and the UK remain globally competitive in clinical research.

Dr Lorch and Richmond Pharmacology has implemented modular training programmes to develop the next generation of clinical pharmacologists, equipped with the capabilities to deliver innovative, adaptive clinical trials safely.

Through her involvement with the Faculty of Pharmaceutical Medicine, Dr Lorch will be empowered with oversight and ownership over the curriculum that equips medical doctors with the skills and experience to become clinical pharmacologists. This provides an opportunity for her to improve training by setting strategic direction and increasing feedback opportunities for trainees.

A skilled scientific workforce is essential to keeping the UK globally competitive. This can only be achieved by an investment in training - equipping scientists and doctors with the skills needed to investigate the latest innovations. If the UK can continue to demonstrate it is developing and retaining top-level clinical researchers, then it will continue to attract a high volume of ground-breaking studies from international drug developers, which will benefit the local patient population and the economy.

Read Dr Lorch’s full Q&A article in MedCity’s newsletter here.

Latest news

Futureproofing early phase clinical research for the next generation of investigators.

March 20, 2023
Richmond Pharmacology’s experienced Principal investigators and Co-investigators recently gave expert feedback on the ICH M11 (CeSHarP) protocol template.
Read more

Director of Operations, Keith Berelowitz, has been appointed as the Research Ethics Committee Chair for the Health Research Authority.

January 19, 2023
Keith Berelowitz will be responsible for ensuring that all ethical possibilities are explored in relation to new research.
Read more


13th International Workshop on Regulatory Requirements and Current Scientific Aspects on the Preclinical and Clinical Investigation of Drug-Drug Interactions

Sunday, June 4th to Tuesday June 6th 2023
Exchange research-based knowledge on drug-drug interactions (DDIs) among all interested stakeholders from pharmaceutical industry, regulatory authorities, academic and health care delivery backgrounds and perspectives.
View event